Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer and researcher of physical and natural sciences based in France. The company possesses both therapeutic and diagnostic rights to validated microRNAs.
This information is reserved for PitchBook Platform users. To explore Actigenics‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.